期刊文献+

C-erbB-2及nm23在乳腺癌中的表达及其临床意义 被引量:2

Expression of C-erbB-2 and nm23 Protein in Breast Carcinoma and Their Clinical Significance
下载PDF
导出
摘要 目的 研究C erbB 2和nm2 3在乳腺癌中的表达及临床预后价值。方法 应用免疫组化S P法检测 6 5例临床随访资料完整的乳腺癌患者标本中 ,C erbB 2和nm2 3的表达情况 ,用Cox回归分析其预后意义。结果 C erbB 2及nm2 3阳性表达率分别为 4 0 %和 5 5 .4 %。C erbB 2表达与腋淋巴结状态呈正相关 ,与生存率呈负相关 ,而nm2 3表达则相反。多因素Cox回归分析显示 ,腋淋巴结状态 ,C erbB 2及nm2 3过度表达等 3项指标反映乳腺癌预后情况 ,危险度分别为3.10 4 6 ,2 .6 5 82 ,0 .370 4。结论 C erbB 2及nm2 3是仅次于乳腺癌腋淋巴结状态的独立的预后指标 ,联合检测可提高其预后价值。 Objective To study the expression and clinical significance of C\|erbB\|2 and nm23 protein in breast carcinoma.Methods Tissue samples from 65 cases of breast carcinoma with full follow\|up data were examined by immunohistochemical S\|P methods and overexpression of their C\|erbB\|2 and nm23 protein was evaluated. Their prognostic value was analyzed by cox regression mode.Results Of the 65 breast carcinoma specimens, 40% were C\|erbB\|2 positive and 55.4% were nm23 positive. Overexpression of C\|erbB\|2 was positively correlated to lymph node involvement and negatively correlated to survival. Overexpression of nm23 was reverse.In both monovariate Kaplan\|Meier plot and multivariate Cox regression analysis, involvement of axillary lymph node, overexpression of C\|erbB\|2 and nm23 were three important prognostic factors of breast carcinoma.The hazard ratios of axillary lymph node involvemnt, overexpression of C\|erbB\|2 and nm23 were 3.1046, 2.6582,0.3704, respectively.Conclusion Expression of C\|erbB\|2 and nm23 could be two useful prognostic indicators only inferior to axillary lymph node of breast carcinoma.
作者 王涛 周云峰
出处 《肿瘤防治研究》 CAS CSCD 2001年第6期454-456,共3页 Cancer Research on Prevention and Treatment
关键词 乳腺癌 C-erB-2基因 NM23基因 预后 基因表达 breast carcinoma C\|erbB\|2 gene,nm23 gene prognosis
  • 相关文献

参考文献1

  • 1Heimann R,Cancer Res,1998年,58卷,2766页

同被引文献13

  • 1毛杰,海健,舒衡平,唐利立,申正堂,邬玉辉,欧慧英.乳腺癌组织中survivin,p53蛋白的表达与预后的关系[J].中国普通外科杂志,2005,14(4):265-268. 被引量:25
  • 2张晓雨,周建农,张彤.survivin、VEGF及Ki67在结直肠癌中的表达及其临床意义[J].肿瘤防治研究,2007,34(1):35-38. 被引量:18
  • 3谈珂岚,丰美芳,王旭芬.乳腺癌中p27表达的临床意义及其与C-erbB-2、p53的关系[J].江苏医药,2007,33(6):577-578. 被引量:2
  • 4McCarthy EP, Ngo LH, Roetzheim RG, et al. Disparitiesin breast cancer treatment and survival for women with disabilities[J]. Ann Intern Med,2006,145(9): 637-645.
  • 5Yip KW, Shi W, Pintilie M, et al. Prognostic significance of the Epstein-Barr virus, p53, bcl-2, and survivin in nasopJaaryngeal cancer[J]. Clin Cancer Res, 2006, 12 (19):5726-5732.
  • 6Bowen AR, Hanks AN, Murphy KJ, et al. Proliferation, apoptosis and survivin expression in keratinoeytic neoplasms and hyperplasias[J]. Am J Dermatopathol,2004,26 (3) : 177-181.
  • 7Ahieri DC. survivin, versatile modulation of cell division and apoptosis in cancer[J]. Oneogene, 2003, 22 (53):8581-8589.
  • 8Span PN, Tjan HeijnenVC, Manders P, et al.'High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer[J]. Breast Cancer Res Treat, 2006,98 (2) : 223-230.
  • 9Karabatsou K, Pal P, Dodd S, et al. Expression of survivin, platelet-derived growth factor A(PDGF A) and PDGF receptor alpha in primary central nervous system Iymphoma[J]. Neu rooncol, 2006,79(2) : 171-179.
  • 10Gerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation[J]. Int J Cancer, 1983,31 ( 1 ) : 13-20.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部